Abstract
The accumulation of DNA damage and subsequent decline in cellular functions are significant factors contributing to aging and-age associated neurodegeneration. Mutations in the genes involved in DNA repair pathways have been linked to premature aging and age-related neurodegeneration. Although DNA repair mechanisms are remarkably preserved across species, our current knowledge of neuronal-specific DNA repair pathways largely stems from investigations carried out on cellular and animal models, mainly focusing on cancer-related research. While DNA repair mechanisms are generally efficient in correcting damage caused by internal and external sources, the regulation of these mechanisms in post-mitotic neuronal cells, which are non-dividing, is not well understood. Studies utilizing autopsy brain samples have identified specific types of DNA damage and repair proteins in human neurons. However, these findings are inadequate to fully understand the regulatory aspects of neuronal-specific DNA repair pathways. This understanding is crucial for developing mechanism-based drugs that can prevent neuronal cell death, a characteristic feature of neurodegenerative diseases. As a result, further research is required to understand the intricate regulation of the DNA repair mechanisms involved in maintaining genome integrity in neurons. Several chemotherapeutic drugs cause DNA damage or impede cell division and cell death. Drugs that are primarily known to induce DNA damage in dividing cells can also damage neuronal DNA. In this context, we propose that it may be worthwhile to consider the DNA damage response induced by chemotherapy in cancer survivors as a tool to understand definite neuronal DNA repair mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
All the raw data generated in this study are available from corresponding authors on request.
Abbreviations
- NDD:
-
Neurodegenerative diseases
- AD:
-
Alzheimer's disease
- PD:
-
Parkinson's disease
- HD:
-
Huntington's disease
- ALS:
-
Amyotrophic lateral sclerosis
- FTD:
-
Frontotemporal dementia
- DDR:
-
DNA damage response
- HR:
-
Homologous recombination
- NHEJ:
-
Non-homologous end joining
- BER:
-
Base excision repair
- NER:
-
Nucleotide excision repair
- SSB:
-
Single-strand breaks
- DSB:
-
Double-strand breaks
- APE1:
-
Apurinic/apyrimidinic endonucleases 1
- 8-oxoG:
-
8-Oxoguanosine
- 8-OHdG:
-
8-Hydroxydeoxyguanosine
- PARP-1:
-
Poly-(ADP-ribose) polymerase 1
- AT:
-
Ataxia telangiectasia
- ATM:
-
Ataxia telangiectasia mutated
- XP:
-
Xeroderma pigmentosum
- CS:
-
Cockayne’s syndrome
- TLS:
-
Translesion synthesis
- PLA2G6:
-
Phospholipase A2 gene
- CICI:
-
Chemotherapy-induced cognitive impairment
References
Anderson, A. J., Stoltzner, S., Lai, F., Su, J., & Nixon, R. A. (2000). Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL. Neurobiology of Aging, 21(4), 511–524. https://doi.org/10.1016/s0197-4580(00)00126-3
Bagnall-Moreau, C., Chaudhry, S., Salas-Ramirez, K., Ahles, T., & Hubbard, K. (2019). Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Molecular Neurobiology, 56(10), 7159–7172. https://doi.org/10.1007/s12035-019-1589-z
Ball, L. G., & Xiao, W. (2005). Molecular basis of ataxia telangiectasia and related diseases. Acta Pharmacologica Sinica, 26(8), 897–907. https://doi.org/10.1111/j.1745-7254.2005.00165.x
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., Taylor, R. W., & Turnbull, D. M. (2006). High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nature Genetics, 38(5), 515–517. https://doi.org/10.1038/ng1769
Bhatia, R., Holtan, S., Jurdi, N. E., Prizment, A., & Blaes, A. (2022). Do cancer and cancer treatments accelerate aging? Current Oncology Reports, 24(11), 1401–1412. https://doi.org/10.1007/s11912-022-01311-2
Billingsley, K. J., Barbosa, I. A., Bandrés-Ciga, S., Quinn, J. P., Bubb, V. J., Deshpande, C., Botia, J. A., Reynolds, R. H., Zhang, D., Simpson, M. A., Blauwendraat, C., Gan-Or, Z., Gibbs, J. R., Nalls, M. A., & Singleton, A. (2019). Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset. NPJ Parkinson’s Disease, 5, 8. https://doi.org/10.1038/s41531-019-0080-x
Bishop, D. T., Demenais, F., Iles, M. M., Harland, M., Taylor, J. C., Corda, E., Randerson-Moor, J., Aitken, J. F., Avril, M. F., Azizi, E., Bakker, B., Bianchi-Scarrà, G., Bressac-de Paillerets, B., Calista, D., Cannon-Albright, L. A., Chin-A-Woeng, T., Debniak, T., Galore-Haskel, G., Ghiorzo, P., et al. (2009). Genome-wide association study identifies three loci associated with melanoma risk. Nature Genetics, 41(8), 920–925. https://doi.org/10.1038/ng.411
Brambati, A., Zardoni, L., Nardini, E., Pellicioli, A., & Liberi, G. (2020). The dark side of RNA:DNA hybrids. Mutation Research, Reviews in Mutation Research, 784, 108300. https://doi.org/10.1016/j.mrrev.2020.108300
Branca, J. J. V., Maresca, M., Morucci, G., Becatti, M., Paternostro, F., Gulisano, M., Ghelardini, C., Salvemini, D., Di Ceseare Mannelli, L., & Pacini, A. (2018). Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity. Oncotarget, 9(34), 23426–23438. https://doi.org/10.18632/oncotarget.25193
Branzei, D., & Foiani, M. (2008). Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Bio, 9(4), 297–308. https://doi.org/10.1038/nrm2351
Browne, S. E., Bowling, A. C., MacGarvey, U., Baik, M. J., Berger, S. C., Muqit, M. M., Bird, E. D., & Beal, M. F. (1997). Oxidative damage and metabolic dysfunction in Huntington’s disease: selective vulnerability of the basal ganglia. Annals of Neurology, 41(5), 646–653. https://doi.org/10.1002/ana.410410514
Burguillos, M. A., Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., & Joseph, B. (2011). Caspase signalling controls microglia activation and neurotoxicity. Nature, 472(7343), 319–324. https://doi.org/10.1038/nature09788
Caron, J. E., Krull, K. R., Hockenberry, M., Jain, N., Kaemingk, K., & Moore, I. M. (2009). Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatric Blood & Cancer, 53(4), 551–556. https://doi.org/10.1002/pbc.22128
Cenini, G., Sultana, R., Memo, M., & Butterfield, D. A. (2008). Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer’s disease. Journal of Cellular and Molecular Medicine, 12(3), 987–994. https://doi.org/10.1111/j.1582-4934.2008.00163.x
Chen, W., Arroyo, J. D., Timmons, J. C., Possemato, R., & Hahn, W. C. (2005). Cancer-associated PP2A alpha subunits induce functional haploin sufficiency and tumorigenicity. Cancer Research, 65(18), 8183–8192. https://doi.org/10.1158/0008-5472.CAN-05-1103
Ciccia, A., & Elledge, S. J. (2010). The DNA damage response: making it safe to play with knives. Molecular Cell, 40(2), 179–204. https://doi.org/10.1016/j.molcel.2010.09.019
Conroy, S. K., McDonald, B. C., Smith, D. J., Moser, L. R., West, J. D., Kamendulis, L. M., Klaunig, J. E., Champion, V. L., Unverzagt, F. W., & Saykin, A. J. (2013). Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Research and Treatment, 137(2), 493–502. https://doi.org/10.1007/s10549-012-2385-x
Coppedè, F. (2010). Mutations involved in premature-ageing syndromes. The Application of Clinical Genetics, 14, 279–295. https://doi.org/10.2147/TACG.S273525
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., McKee, A. C., Beal, M. F., Graham, B. H., & Wallace, D. C. (1994). Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics, 23(2), 471–476. https://doi.org/10.1006/geno.1994.1525
Cunniff, C., Bassetti, J. A., & Ellis, N. A. (2017). Bloom’s Syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition. Molecular Syndromology, 8(1), 4–23. https://doi.org/10.1159/000452082
Cupit-Link, M. C., Kirkland, J. L., Ness, K. K., Armstrong, G. T., Tchkonia, T., LeBrasseur, N. K., Armenian, S. H., Ruddy, K. J., & Hashmi, S. K. (2017). Biology of premature ageing in survivors of cancer. ESMO Open, 2, e000250. https://doi.org/10.1136/esmoopen-2017-000250
Dabin, J., Mori, M., & Polo, S. E. (2023). The DNA damage response in the chromatin context: a coordinated process. Current Opinion in Cell Biology, 82, 102176. https://doi.org/10.1016/j.ceb.2023.102176
de Souza-Pinto, N. C., Wilson, D. M., 3rd., Stevnsner, T. V., & Bohr, V. A. (2008). Mitochondrial DNA, base excision repair and neurodegeneration. DNA Repair (amst), 7(7), 1098–1109. https://doi.org/10.1016/j.dnarep.2008.03.011
Didier, M., Bursztajn, S., Adamec, E., Passani, L., Nixon, R. A., Coyle, J. T., Wei, J. Y., & Berman, S. A. (1996). DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. The Journal of Neuroscience, 16(7), 2238–2250. https://doi.org/10.1523/JNEUROSCI.16-07-02238.1996
Enokido, Y., Tamura, T., Ito, H., Arumughan, A., Komuro, A., Shiwaku, H., Sone, M., Foulle, R., Sawada, H., Ishiguro, H., Ono, T., Murata, M., Kanazawa, I., Tomilin, N., Tagawa, K., Wanker, E. E., & Okazawa, H. (2010). Mutant huntingtin impairs Ku70-mediated DNA repair. The Journal of Cell Biology, 189, 425–443. https://doi.org/10.1083/jcb.200905138
Farg, M. A., Konopka, A., Soo, K. Y., Ito, D., & Atkin, J. D. (2017). The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Human Molecular Genetics, 26(15), 2882–2896. https://doi.org/10.1093/hmg/ddx170
Flanary, B. E., & Streit, W. J. (2004). Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes. Glia, 45(1), 75–88. https://doi.org/10.1002/glia.10301
Gao, X., Simon, K. C., Han, J., Schwarzschild, M. A., & Ascherio, A. (2009). Family history of melanoma and Parkinson disease risk. Neurology, 73(16), 1286–1291. https://doi.org/10.1212/WNL.0b013e3181bd13a1
Ghosh, A., Saminathan, H., Kanthasamy, A., Anantharam, V., Jin, H., Sondarva, G., Harischandra, D. S., Qian, Z., Rana, A., & Kanthasamy, A. G. (2013). The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease. The Journal of Biological Chemistry, 288(30), 21955–21971. https://doi.org/10.1074/jbc.M112.444224
Giannini, M., Bayona-Feliu, A., Sproviero, D., Barroso, S. I., Cereda, C., & Aguilera, A. (2020). TDP-43 mutations link amyotrophic lateral sclerosis with R-loop homeostasis and R loop-mediated DNA damage. PLoS Genetics, 16(12), e1009260. https://doi.org/10.1371/journal.pgen.1009260
Goto, M. (1997). Hierarchical deterioration of body systems in Werner’s syndrome: implications for normal ageing. Mechanisms of Ageing and Development, 98(3), 239–254. https://doi.org/10.1016/s0047-6374(97)00111-5
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., Edkins, S., O’Meara, S., Vastrik, I., Schmidt, E. E., Avis, T., Barthorpe, S., Bhamra, G., Buck, G., Choudhury, B., et al. (2007). Patterns of somatic mutation in human cancer genomes. Nature, 446(7132), 153–158. https://doi.org/10.1038/nature05610
Gu, G., Reyes, P. E., Golden, G. T., Woltjer, R. L., Hulette, C., Montine, T. J., & Zhang, J. (2002). Mitochondrial DNA deletions/rearrangements in Parkinson disease and related neurodegenerative disorders. Journal of Neuropathology and Experimental Neurology, 61(7), 634–639. https://doi.org/10.1093/jnen/61.7.634
Guida, J. L., Ahles, T. A., Belsky, D., Campisi, J., Cohen, H. J., DeGregori, J., Fuldner, R., Ferrucci, L., Gallicchio, L., Gavrilov, L., Gavrilova, N., Green, P. A., Jhappan, C., Kohanski, R., Krull, K., Mandelblatt, J., Ness, K. K., O’Mara, A., Price, N., et al. (2019). Measuring aging and identifying aging phenotypes in cancer survivors. Journal of the National Cancer Institute, 111, 1245–1254. https://doi.org/10.1093/jnci/djz136
Gupta, S., You, P., SenGupta, T., Nilsen, H., & Sharma, K. (2021). Crosstalk between different DNA repair pathways contributes to neurodegenerative diseases. Biology (basel), 10(2), 163. https://doi.org/10.3390/biology10020163
Hegde, M. L., Bohr, V. A., & Mitra, S. (2017). DNA damage responses in central nervous system and age-associated neurodegeneration. Mechanisms of Ageing and Development, 161(Pt A), 1–3. https://doi.org/10.1016/j.mad.2017.01.010
Hegde, M. L., Mantha, A. K., Hazra, T. K., Bhakat, K. K., Mitra, S., & Szczesny, B. (2012). Oxidative genome damage and its repair: Implications in aging and neurodegenerative diseases. Mechanisms of Ageing and Development, 133(4), 157–168. https://doi.org/10.1016/j.mad.2012.01.005
Hoeijmakers, J. H. J. (2009). DNA damage, aging, and cancer. The New England Journal of Medicine, 361, 1475–1485. https://doi.org/10.1056/NEJMra0804615
Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A. L., Degregori, J., Oertel, W. H., Rakic, P., Hirsch, E. C., & Hunot, S. (2007). The pRb/E2F cell-cycle pathway mediates cell death in Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America, 104(9), 3585–3590. https://doi.org/10.1073/pnas.0611671104
Huang, R., & Zhou, P. K. (2021). DNA damage repair: Historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduction and Targeted Therapy, 6(1), 254. https://doi.org/10.1038/s41392-021-00648-7
Huertas, P., & Aguilera, A. (2003). Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Molecular Cell, 12(3), 711–721. https://doi.org/10.1016/j.molcel.2003.08.010
Ibanez, K., Boullosa, C., Tabares-Seisdedos, R., Baudot, A., & Valencia, A. (2014). Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genetics, 10(2), e1004173. https://doi.org/10.1371/journal.pgen.1004173
Iyama, T., & Wilson, D. M., 3rd. (2013). DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (amst), 12(8), 620–636. https://doi.org/10.1016/j.dnarep.2013.04.015
Jensen, H. L. B., Lillenes, M. S., Rabano, A., Günther, C. C., Riaz, T., Kalayou, S. T., Ulstein, I. D., & Bøhmer, T. (2018). Expression of nucleotide excision repair in Alzheimer’s disease is higher in brain tissue than in blood. Neuroscience Letters, 672, 53–58. https://doi.org/10.1016/j.neulet.2018.02.043
John, J., Kinra, M., Mudgal, J., Viswanatha, G. L., & Nandakumar, K. (2021). Animal models of chemotherapy-induced cognitive decline in preclinical drug development. Psychopharmacology (berl), 238(11), 3025–3053. https://doi.org/10.1007/s00213-021-05977-7
Karahalil, B., Hogue, B. A., de Souza-Pinto, N. C., & Bohr, V. A. (2002). Base excision repair capacity in mitochondria and nuclei: Tissue-specific variations. FASEB Journal, 16(14), 1895–1902. https://doi.org/10.1096/fj.02-0463com
Kelland, L. (2007). The resurgence of platinum-based cancer chemotherapy. Nature Reviews Cancer, 7(8), 573–584. https://doi.org/10.1038/nrc2167
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392(6676), 605–608. https://doi.org/10.1038/33416
Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y., & Taniguchi, T. (1997). Changes of p53 in the brains of patients with Alzheimer’s disease. Biochemical and Biophysical Research Communications, 232(2), 418–421. https://doi.org/10.1006/bbrc.1997.6301
Klein, C., Lohmann-Hedrich, K., Rogaeva, E., Schlossmacher, M. G., & Lang, A. E. (2007). Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurology, 6(7), 652–662. https://doi.org/10.1016/S1474-4422(07)70174-6
Krasikova, Y., Rechkunova, N., & Lavrik, O. (2021). Nucleotide excision repair: from molecular defects to neurological abnormalities. International Journal of Molecular Sciences, 22(12), 6220. https://doi.org/10.3390/ijms22126220
Leandro, G. S., Sykora, P., & Bohr, V. A. (2015). The impact of base excision DNA repair in age-related neurodegenerative diseases. Mutation Research., 776, 31–39. https://doi.org/10.1016/j.mrfmmm.2014.12.011
Lee, K. H., Lee, S. J., Lee, H. J., Choi, G. E., Jung, Y. H., Kim, D. I., Gabr, A. A., Ryu, J. M., & Han, H. J. (2017). Amyloid beta1-42 (Abeta1-42) induces the CDK2-mediated phosphorylation of tau through the activation of the mTORC1 signaling pathway while promoting neuronal cell death. Frontiers in Molecular Neuroscience, 10, 229. https://doi.org/10.3389/fnmol.2017.00229
Li, X., Cao, G., Liu, X., Tang, T. S., Guo, C., & Liu, H. (2022). Polymerases and DNA repair in neurons: implications in neuronal survival and neurodegenerative diseases. Frontiers in Cellular Neuroscience, 16, 852002. https://doi.org/10.3389/fncel.2022.852002
Lillenes, M. S., Rabano, A., Støen, M., Riaz, T., Misaghian, D., Møllersen, L., Esbensen, Y., Günther, C. C., Selnes, P., Stenset, V. T., Fladby, T., & Tønjum, T. (2016). Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease. Molecular Brain, 9(1), 61. https://doi.org/10.1186/s13041-016-0237-z
Lin, M. T., Cantuti-Castelvetri, I., Zheng, K., Jackson, K. E., Tan, Y. B., Arzberger, T., Lees, A. J., Betensky, R. A., Beal, M. F., & Simon, D. K. (2012). Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Annals of Neurology, 71(6), 850–854. https://doi.org/10.1002/ana.23568
Lin, M. T., Simon, D. K., Ahn, C. H., Kim, L. M., & Beal, M. F. (2002). High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer’s disease brain. Human Molecular Genetics, 11(2), 133–145. https://doi.org/10.1093/hmg/11.2.133
Liou, Y. C., Sun, A., Ryo, A., Zhou, X. Z., Yu, Z. X., Huang, H. K., Uchida, T., Bronson, R., Bing, G., Li, X., Hunter, T., & Lu, K. P. (2003). Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature, 424(6948), 556–561. https://doi.org/10.1038/nature01832
Liu, J., & Wang, F. (2017). Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Frontiers in Immunology, 8, 1005. https://doi.org/10.3389/fimmu.2017.01005
Lu, T., Pan, Y., Kao, S. Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004). Gene regulation and DNA damage in the ageing human brain. Nature, 429(6994), 883–891. https://doi.org/10.1038/nature02661
Luquette, L. J., Miller, M. B., Zhou, Z., Bohrson, C. L., Zhao, Y., Jin, H., Gulhan, D., Ganz, J., Bizzotto, S., Kirkham, S., Hochepied, T., Libert, C., Galor, A., Kim, J., Lodato, M. A., Garaycoechea, J. I., Gawad, C., West, J., Walsh, C. A., & Park, P. J. (2022). Single-cell genome sequencing of human neurons identifies somatic point mutation and indel enrichment in regulatory elements. Nature Genetics, 54(10), 1564–1571. https://doi.org/10.1038/s41588-022-01180-2
Macdonald, D. R. (1991). Neurologic complications of chemotherapy. Neurologic Clinics, 9(4), 955–967.
Magge, R. S., & DeAngelis, L. M. (2015). The double-edged sword: neurotoxicity of chemotherapy. Blood Reviews, 29(2), 93–100. https://doi.org/10.1016/j.blre.2014.09.012
Magrinelli, F., Mehta, S., Di Lazzaro, G., Latorre, A., Edwards, M. J., Balint, B., Basu, P., Kobylecki, C., Groppa, S., Hegde, A., Mulroy, E., Estevez-Fraga, C., Arora, A., Kumar, H., Schneider, S. A., Lewis, P. A., Jaunmuktane, Z., Revesz, T., Gandhi, S., et al. (2022). Dissecting the phenotype and genotype of PLA2G6-related parkinsonism. Movement Disorders, 37(1), 148–161. https://doi.org/10.1002/mds.28807
Manchon, J. F., Dabaghian, Y., Uzor, N. E., Kesler, S. R., Wefel, J. S., & Tsvetkov, A. S. (2016). Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons. Scientific Reports, 6, 25705. https://doi.org/10.1038/srep25705
McKinnon, P. J. (2009). DNA repair deficiency and neurological disease. Nature Reviews Neuroscience, 10(2), 100–112. https://doi.org/10.1038/nrn2559
McKinnon, P. J. (2017). Genome integrity and disease prevention in the nervous system. Genes & Development, 31(12), 1180–1194. https://doi.org/10.1101/gad.301325.117
McShea, A., Harris, P. L., Webster, K. R., Wahl, A. F., & Smith, M. A. (1997). Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer’s disease. The American Journal of Pathology, 150(6), 1933–1939.
Mitra, J., Guerrero, E. N., Hegde, P. M., Liachko, N. F., Wang, H., Vasquez, V., Gao, J., Pandey, A., Taylor, J. P., Kraemer, B. C., Wu, P., Boldogh, I., Garruto, R. M., Mitra, S., & RaoHegde, K. S. M. L. (2019). Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proceedings of the National Academy of Sciences of the United States of America, 116(10), 4696–4705. https://doi.org/10.1073/pnas.1818415116
Mogi, M., Kondo, T., Mizuno, Y., & Nagatsu, T. (2007). p53 protein, interferon-gamma, and NF-kappa B levels are elevated in the parkinsonian brain. Neuroscience Letters, 414(1), 94–97. https://doi.org/10.1016/j.neulet.2006.12.003
Morgan, S. L., Naderi, P., Koler, K., Pita-Juarez, Y., Prokopenko, D., Vlachos, I. S., Tanzi, R. E., Bertram, L., & Hide, W. A. (2022). Most pathways can be related to the pathogenesis of Alzheimer’s disease. Frontiers in Aging Neuroscience, 14, 846902. https://doi.org/10.3389/fnagi.2022.846902
Naumann, M., Pal, A., Goswami, A., Lojewski, X., Japtok, J., Vehlow, A., Naujock, M., Günther, R., Jin, M., Stanslowsky, N., Reinhardt, P., Sterneckert, J., Frickenhaus, M., Pan-Montojo, F., Storkebaum, E., Poser, I., Freischmidt, A., Weishaupt, J. H., Holzmann, K., et al. (2018). Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nature Communications, 9(1), 335. https://doi.org/10.1038/s41467-017-02299-1
Nonnekens, J., & Hoeijmakers, J. H. (2017). After surviving cancer, what about late life effects of the cure? EMBO Molecular Medicine, 9, 4–6. https://doi.org/10.15252/emmm.201607062
Nouspikel, T., & Hanawalt, P. C. (2000). Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Molecular and Cellular Biology, 20(5), 1562–1570. https://doi.org/10.1128/MCB.20.5.1562-1570.2000
Paisan-Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A., & Schneider, S. A. (2009). Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Annals of Neurology, 65(1), 19–23. https://doi.org/10.1002/ana.21415
Pani, B., & Nudler, E. (2017). Mechanistic insights into transcription coupled DNA repair. DNA Repair (amst), 56, 42–50. https://doi.org/10.1016/j.dnarep.2017.06.006
Park, H. J., Lee, K. W., Park, E. S., Oh, S., Yan, R., Zhang, J., Beach, T. G., Adler, C. H., Voronkov, M., Braithwaite, S. P., Stock, J. B., & Mouradian, M. M. (2016). Dysregulation of protein phosphatase 2A in Parkinson disease and dementia with Lewy bodies. Annals of Clinical and Translational Neurology, 3(10), 769–780. https://doi.org/10.1002/acn3.337
Park, J. S., Lee, J., Jung, E. S., Kim, M. H., Kim, I. B., Son, H., Kim, S., Kim, S., Park, Y. M., Mook-Jung, I., Yu, S. J., & Lee, J. H. (2019). Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation. Nature Communications, 10(1), 3090. https://doi.org/10.1038/s41467-019-11000-7
Petsalaki, E., & Zachos, G. (2020). DNA damage response proteins regulating mitotic cell division: double agents preserving genome stability. FEBS Journal, 287(9), 1700–1721. https://doi.org/10.1111/febs.15240
Polidori, M. C., Mecocci, P., Browne, S. E., Senin, U., & Beal, M. F. (1999). Oxidative damage to mitochondrial DNA in Huntington’s disease parietal cortex. Neuroscience Letters, 272, 53–56. https://doi.org/10.1016/s0304-3940(99)00578-9
Reid, D. A., Reed, P. J., Schlachetzki, J. C. M., Nitulescu, I. I., Chou, G., Tsui, E. C., Jones, J. R., Chandran, S., Lu, A. T., McClain, C. A., Ooi, J. H., Wang, T. W., Lana, A. J., Linker, S. B., Ricciardulli, A. S., Lau, S., Schafer, S. T., Horvath, S., Dixon, J. R., et al. (2021). Incorporation of a nucleoside analog maps genome repair sites in postmitotic human neurons. Science, 372(6537), 91–94. https://doi.org/10.1126/science.abb9032
Ren, X., Boriero, D., Chaiswing, L., Bondada, S., St Clair, D. K., & Butterfield, D. A. (2019). Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors. Biochimica Et Biophysica Acta, Molecular Basis of Disease, 1865(6), 1088–1097. https://doi.org/10.1016/j.bbadis.2019.02.007
Roe, C. M., Fitzpatrick, A. L., Xiong, C., Sieh, W., Kuller, L., Miller, J. P., Williams, M. M., Kopan, R., Behrens, M. I., & Morris, J. C. (2010). Cancer linked to Alzheimer disease but not vascular dementia. Neurology, 74(2), 106–112. https://doi.org/10.1212/WNL.0b013e3181c91873
Santos, R. X., Correia, S. C., Zhu, X., Smith, M. A., Moreira, P. I., Castellani, R. J., Nunomura, A., & Perry, G. (2013). Mitochondrial DNA oxidative damage and repair in aging and Alzheimer’s disease. Antioxidants & Redox Signaling, 18(18), 2444–2457. https://doi.org/10.1089/ars.2012.5039
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021). The central role of DNA damage in the ageing process. Nature, 592(7856), 695–703. https://doi.org/10.1038/s41586-021-03307-7
Seo, J., & Park, M. (2020). Molecular crosstalk between cancer and neurodegenerative diseases. Cellular and Molecular Life Sciences, 77(14), 2659–2680. https://doi.org/10.1007/s00018-019-03428-3
Shackelford, D. A. (2006). DNA end joining activity is reduced in Alzheimer’s disease. Neurobiology of Aging, 27, 596–605. https://doi.org/10.1016/j.neurobiolaging.2005.03.009
Shadfar, S., Brocardo, M., & Atkin, J. D. (2022). he Complex mechanisms by which neurons die following DNA damage in neurodegenerative diseases. International Journal of Molecular Sciences, 23(5), 2484. https://doi.org/10.3390/ijms23052484
Shafqat, S., Arana Chicas, E., Shafqat, A., & Hashmi, S. K. (2022). The Achilles’ heel of cancer survivors: fundamentals of accelerated cellular senescence. The Journal of Clinical Investigation, 132(13), e158452. https://doi.org/10.1172/JCI158452
Shanbhag, N. M., Evans, M. D., Mao, W., Nana, A. L., Seeley, W. W., Adame, A., Rissman, R. A., Masliah, E., & Mucke, L. (2019). Early neuronal accumulation of DNA double strand breaks in Alzheimer’s disease. Acta Neuropathologica Communications, 7(1), 77. https://doi.org/10.1186/s40478-019-0723-5
Shibata, A., & Jeggo, P. A. (2021). ATM’s role in the repair of DNA double-strand breaks. Genes (basel), 12(9), 1370. https://doi.org/10.3390/genes12091370
Sioka, C., & Kyritsis, A. P. (2009). Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemotherapy and Pharmacology, 63(5), 761–767. https://doi.org/10.1007/s00280-008-0876-6
Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., & White, C. L., 3rd. (2004). Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. Journal of Neuropathology and Experimental Neurology, 63(4), 287–301. https://doi.org/10.1093/jnen/63.4.287
Sørensen, S. A., Fenger, K., & Olsen, J. H. (1999). Significantly lower incidence of cancer among patients with Huntington disease: an apoptotic effect of an expanded polyglutamine tract? Cancer, 86(7), 1342–1346.
Stefanatos, R., & Sanz, A. (2018). The role of mitochondrial ROS in the aging brain. FEBS Letters, 592(5), 743–758. https://doi.org/10.1002/1873-3468.12902
Suberbielle, E., Djukic, B., Evans, M., Kim, D. H., Taneja, P., Wang, X., Finucane, M., Knox, J., Ho, K., Devidze, N., Masliah, E., & Mucke, L. (2015). DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice. Nature Communications, 6, 8897. https://doi.org/10.1038/ncomms9897
Sullivan, R., Yau, W. Y., O’Connor, E., & Houlden, H. (2019). Spinocerebellar ataxia: An update. Journal of Neurology, 266(2), 533–544. https://doi.org/10.1007/s00415-018-9076-4
Taillibert, S., Le Rhun, E., & Chamberlain, M. C. (2016). Chemotherapy-related neurotoxicity. Current Neurology and Neuroscience Reports., 16(9), 81. https://doi.org/10.1007/s11910-016-0686-x
Thadathil, N., Delotterie, D. F., Xiao, J., Hori, R., McDonald, M. P., & Khan, M. M. (2021). DNA double-strand break accumulation in Alzheimer’s disease: evidence from experimental models and postmortem human brains. Molecular Neurobiology, 58(1), 118–131. https://doi.org/10.1007/s12035-020-02109-8
Torre, M., Dey, A., Woods, J. K., & Feany, M. B. (2021). Elevated oxidative stress and DNA damage in cortical neurons of chemotherapy patients. Journal of Neuropathology and Experimental Neurology, 80(7), 705–712. https://doi.org/10.1093/jnen/nlab074
Urulangodi, M., & Mohanty, A. (2020). DNA damage response and repair pathway modulation by non-histone protein methylation: Implications in neurodegeneration. J Cell Communication and Signaling, 14(1), 31–45. https://doi.org/10.1007/s12079-019-00538-2
van den Boogaard, W. M. C., Komninos, D. S. J., & Vermeij, W. P. (2022). Chemotherapy side-effects: not all DNA damage is equal. Cancers (basel), 14(3), 627. https://doi.org/10.3390/cancers14030627
van der Plas, E., Nieman, B. J., Butcher, D. T., Hitzler, J. K., Weksberg, R., Ito, S., & Schachar, R. (2015). Neurocognitive late effects of chemotherapy in survivors of acute lymphoblastic leukemia: Focus on methotrexate. Journal of Canadian Academy of Child and Adolescent Psychiatry, 24(1), 25–32.
Veeriah, S., Taylor, B. S., Meng, S., Fang, F., Yilmaz, E., Vivanco, I., Janakiraman, M., Schultz, N., Hanrahan, A. J., Pao, W., Ladanyi, M., Sander, C., Heguy, A., Holland, E. C., Paty, P. B., Mischel, P. S., Liau, L., Cloughesy, T. F., Mellinghoff, I. K., et al. (2010). Somatic mutations of the Parkinson’s disease-associated gene PARK2 in glioblastoma and other human malignancies. Nature Genetics, 42(1), 77–82. https://doi.org/10.1038/ng.491
Wang, D., Wu, W., Callen, E., Pavani, R., Zolnerowich, N., Kodali, S., Zong, D., Wong, N., Noriega, S., Nathan, W. J., Matos-Rodrigues, G., Chari, R., Kruhlak, M. J., Livak, F., Ward, M., Caldecott, K., Di Stefano, B., & Nussenzweig, A. (2022). Active DNA demethylation promotes cell fate specification and the DNA damage response. Science, 378(6623), 983–989. https://doi.org/10.1126/science.add9838
Weissman, L., Jo, D. G., Sørensen, M. M., de Souza-Pinto, N. C., Markesbery, W. R., Mattson, M. P., & Bohr, V. A. (2007). Defective DNA base excision repair in brain from individuals with Alzheimer’s disease and amnestic mild cognitive impairment. Nucleic Acids Research, 35(16), 5545–5555. https://doi.org/10.1093/nar/gkm605
Welch, G., & Tsai, L. H. (2022). Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease. EMBO Reports, 23, e54217. https://doi.org/10.15252/embr.202154217
Wieland, L. S., Moffet, I., Shade, S., Emadi, A., Knott, C., Gorman, E. F., & D’Adamo, C. (2021). Risks and benefits of antioxidant dietary supplement use during cancer treatment: Protocol for a scoping review. British Medical Journal Open, 11(4), e047200. https://doi.org/10.1136/bmjopen-2020-047200
Williams, K. L., Topp, S., Yang, S., Smith, B., Fifita, J. A., Warraich, S. T., Zhang, K. Y., Farrawell, N., Vance, C., Hu, X., Chesi, A., Leblond, C. S., Lee, A., Rayner, S. L., Sundaramoorthy, V., Dobson-Stone, C., Molloy, M. P., van Blitterswijk, M., Dickson, D. W., et al. (2016). CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nature Communications, 7, 11253. https://doi.org/10.1038/ncomms11253
Wu, W., Hill, S. E., Nathan, W. J., Paiano, J., Callen, E., Wang, D., Shinoda, K., van Wietmarschen, N., Colón-Mercado, J. M., Zong, D., De Pace, R., Shih, H. Y., Coon, S., Parsadanian, M., Pavani, R., Hanzlikova, H., Park, S., Jung, S. K., McHugh, P. J., et al. (2021). Neuronal enhancers are hotspots for DNA single-strand break repair. Nature, 593(7859), 440–444. https://doi.org/10.1038/s41586-021-03468-5
Yamamoto, A., Nakamura, Y., Kobayashi, N., Iwamoto, T., Yoshioka, A., Kuniyasu, H., Kishimoto, T., & Mori, T. (2007). Neurons and astrocytes exhibit lower activities of global genome nucleotide excision repair than do fibroblasts. DNA Repair (amst)., 6(5), 649–657. https://doi.org/10.1016/j.dnarep.2006.12.006
Yang, J. L., Tadokoro, T., Keijzers, G., Mattson, M. P., & Bohr, V. A. (2010). Neurons efficiently repair glutamate-induced oxidative DNA damage by a process involving CREB-mediated up-regulation of apurinic endonuclease 1. The Journal of Biological Chemistry, 285(36), 28191–28199. https://doi.org/10.1074/jbc.M109.082883
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023a). Role of neuroinflammation in neurodegeneration development. Signal Transduction and Targeted Therapy, 8(1), 267. https://doi.org/10.1038/s41392-023-01486-5
Zhang, X., Liu, Y., Huang, M., Gunewardena, S., Haeri, M., Swerdlow, R. H., & Wang, N. (2023b). Landscape of double-stranded DNA breaks in postmortem brains from Alzheimer’s disease and non-demented individuals. Journal of Alzheimer’s Disease. https://doi.org/10.3233/JAD-230316
Zukas, A. M., & Schiff, D. (2018). Neurological complications of new chemotherapy agents. Neuro-Oncology, 20(1), 24–36. https://doi.org/10.1093/neuonc/nox115
Acknowledgements
The authors thank Dr. Srinivas Gopala, Dr. Cibin T Raghavan, and all other members of the Department of Biochemistry, SCTIMST, for constant discussion and inputs during the preparation of this review article.
Funding
No extramural funding was received for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Babu, A., Urulangodi, M. Chemotherapy-induced neuronal DNA damage: an intriguing toolbox to elucidate DNA repair mechanisms in the brain. GENOME INSTAB. DIS. 4, 315–332 (2023). https://doi.org/10.1007/s42764-023-00110-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42764-023-00110-8